304 related articles for article (PubMed ID: 37188268)
1. Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.
Chen CY; Xie M; Gong J; Yu N; Wei R; Lei LL; Zhao SM; Li RM; Dong X; Zhang XL; Zhou Y; Li SL; Cui YM
Front Pharmacol; 2023; 14():1132367. PubMed ID: 37188268
[No Abstract] [Full Text] [Related]
2. Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type.
Wang Y; Yao F; Chen S; Ouyang X; Lan J; Wu Z; Wang Y; Chen J; Wang X; Chen C
Drug Des Devel Ther; 2023; 17():2259-2271. PubMed ID: 37546521
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
Song X; Han M
Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of teicoplanin in children.
Ramos-Martín V; Paulus S; Siner S; Scott E; Padmore K; Newland P; Drew RJ; Felton TW; Docobo-Pérez F; Pizer B; Pea F; Peak M; Turner MA; Beresford MW; Hope WW
Antimicrob Agents Chemother; 2014 Nov; 58(11):6920-7. PubMed ID: 25224001
[TBL] [Abstract][Full Text] [Related]
7. Model-based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non-complicated methicillin-resistant staphylococcus aureus infection.
Zhang XS; Chen YL; Wang YZ; Chen C; Chen YJ; Xu FM; Dai Y; Shi DW; Lin GY; Yu XB; Xiang DZ; Zhang CH
Br J Clin Pharmacol; 2024 Feb; 90(2):452-462. PubMed ID: 37749762
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients.
Zhang T; Sun D; Shu Z; Duan Z; Liu Y; Du Q; Zhang Y; Dong Y; Wang T; Hu S; Cheng H; Dong Y
Front Pharmacol; 2020; 11():594562. PubMed ID: 33363469
[No Abstract] [Full Text] [Related]
9. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
[TBL] [Abstract][Full Text] [Related]
11. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Wei X; Zhao M; Xiao X
J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection.
Ogawa R; Kobayashi S; Sasaki Y; Makimura M; Echizen H
Int J Clin Pharmacol Ther; 2013 May; 51(5):357-66. PubMed ID: 23458228
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
He S; Cheng Z; Xie F
Drug Des Devel Ther; 2022; 16():13-22. PubMed ID: 35023902
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients.
Fu WQ; Tian TT; Zhang MX; Song HT; Zhang LL
Front Pharmacol; 2022; 13():1045895. PubMed ID: 36506535
[No Abstract] [Full Text] [Related]
15. Optimal Teicoplanin Dosing Regimen in Neonates and Children Developed by Leveraging Real-World Clinical Information.
Yamada T; Emoto C; Fukuda T; Motomura Y; Inoue H; Ohga S; Ieiri I
Ther Drug Monit; 2022 Jun; 44(3):404-413. PubMed ID: 34629445
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia.
Kang SW; Jo HG; Kim D; Jeong K; Lee J; Lee HJ; Yang S; Park S; Rhie SJ; Chung EK
J Crit Care; 2023 Dec; 78():154402. PubMed ID: 37634293
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections.
Matsumoto K; Watanabe E; Kanazawa N; Fukamizu T; Shigemi A; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
Clin Pharmacol; 2016; 8():15-8. PubMed ID: 27099534
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of teicoplanin against MRSA.
Ramos-Martín V; Johnson A; McEntee L; Farrington N; Padmore K; Cojutti P; Pea F; Neely MN; Hope WW
J Antimicrob Chemother; 2017 Dec; 72(12):3382-3389. PubMed ID: 28962026
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients.
Aulin LBS; De Paepe P; Dhont E; de Jaeger A; Vande Walle J; Vandenberghe W; McWhinney BC; Ungerer JPJ; van Hasselt JGC; De Cock PAJG
Clin Pharmacokinet; 2021 Mar; 60(3):353-363. PubMed ID: 33030704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
